- Microsoft Will Lose a War With Apple; So Will Google
- 10 Worst Cars of All Time
- 10 Cult TV Shows Netflix Should Revive
- Apple Bulls Having Love Fest: Please, Get a Room
- The Sad Story of Jack Welch in Retirement: Opinion
The Second 2012 Presidential Debate: Blog Recap
President Obama and Mitt Romney squared off in a town hall-style tussle. Read insights and analysis from TheStreet's Joe Deaux who attended the event.
Real Money Previews
Doug Kass: Invest Like a Hedge Fund With This ETF
Doug Kass says you can invest like a hedge fund with less fees, lower transaction costs, immediate liquidity and more transparency.
The Day Ahead: Beware of Paper Champions
Stay on your guard for blips of upside that are essentially unjustified.
Gad: Chipotle Is the Future
This Editor's Choice Piece discusses the restaurant chain's significant growth potential.
A Note From Stephanie Link: 10/15
Stephanie Link invites you to try Real Money and Real Money Pro.
Kass: Mr. Market's Road to Perdition
Risk has been unusually heightened for the balance of 2012.
Mad Money Recap
Cramer's 'Mad Money' Recap: Time to Change Your Mind
Investors are focusing on negative news when they should be putting money into the sectors showing positive results, Cramer said.
Stock Ideas
5 Stocks Set to Soar on Bullish Earnings
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
Cramer Quick Take: Presidential Debate Will Trigger Energy Trades
Sell coal stocks ahead of tonight's debate, Cramer advised.
5 Big Trades From the Financial Sector
If 2012 has been a good year for stocks so far, it's been a stellar year for the financial sector.
Apple, Microsoft Need to Innovate, If They Can
Windows 8 is a maybe, and nothing's new under Apple tree.
Jeter Breaks Ankle, Twitter Delivers Eyeballs
Twitter is the biggest thing to happen to media since the invention of television.
Personal Finance
5 Ways Black Friday Holiday Shopping Has Already Begun
Black Friday is already on retailers' minds whether you like it or not. The leaks, deals and marketing have begun.
When Mortgage Lenders Won't Listen, Refinance On Your Own: Prepay
It's not as good as a refinancing, but it's better than doing nothing -- and could win you a refinance down the road.
Ranks of Millionaires Still Soaring by 2017, Study Says
Even in China, where the millionaire growth rate will be higher, the U.S. still winds up with more, Credit Suisse says.
The Digital Skeptic: What Do Banks Do With a Generation That Doesn't Bank?
More and more people have no need for banks because they live fine with little need for the money inside banks.
3 Steps to Buying a Car in One Day
Even though a car is a big-ticket purchase, you can do it quickly and with little stress, Edmunds.com says.
Editors' Picks
|
Options Profits Previews
Woodard: Two VIX Based Signals of Market Risk
We can use these two tests to see whether recent market weakness is reason enough for investors to hedge their portfolios.
Schwartz: Tale of Two Prints
Let's follow up on two significant trades we highlighted in early October.
Najarian/Malandrino WEBINAR: Our Best Ideas
The election is near. For market insight and actionable ideas, join Jon 'DRJ' Najarian of optionMONSTER.com and Jill Malandrino of TheStreet's Options Profits in a special post-market webinar. Don't miss the Q&A session!
Stock Market Today
Dow Rises Triple-Digits; S&P 500, Nasdaq Notch 1%-Plus Gains
U.S. stocks finish sharply higher after a batch of strong earnings reports from big-cap companies and data shows a rebound in industrial production.
Biotech Stocks
NPS Pharma FDA Panel Live Blog
An FDA panel weighs the risk and benefits of NPS Pharma's Gattex.
Lexicon Pharma: Blockbuster Potential From A Diabetes Drug
Lexicons mid-stage diabetes drug blocks the reabsorption of blood sugar.
Abbott Hep C Therapy Achieves Almost-Perfect Cure Rate
Abbott establishes itself a strong player in the race to develop new, all-oral hepatitis C regimens.
Latest Videos
Pandit Resigns, Markets Rally, More Economic Data to Come
The resignation of Citi's CEO, Vikram Pandit, dominated headlines, but improving economic data was the driver of markets today.
Don't Follow the Investment Crowd
Senior Editor at Large of Fortune Magazine, Allan Sloan says when it comes to investing you're not better off doing what everyone else is doing.
Microsoft Surface: No Price War
Microsoft is pricing its Surface tablet the same as Apple's iPad. Apple is focused on the iPad mini.
Deal News
SiriusXM Stock Surge May Not End in 2012
SiriusXM's stock may ride auto market boom in 2013
Goldman Sachs Can Fall Off the Fiscal Cliff
After a great third quarter, Goldman Sachs investors may plunge with the fiscal cliff.
Sprint, Softbank Deal a Consumer Win
In a wild year for telecoms, Sprint's takeout by Softbank of Japan has investors and consumers poised to win.
Between the Lines
Jim Cramer
Cramer: Presidential Debate Will Trigger Energy Trades
Jim Cramer believes the second presidential debate will affect the energy sector. Watch coal and green energy.
James Rogers
IBM Shares Slip on Revenue Miss (Update 1)
The Dow component edges past Wall Street's earnings forecast in its third-quarter results, but currency pressures weighs heavily on the top line.
Chris Ciaccia
Intel Tops Lowered Earnings Expectations
The chip giant's stock is sliding in late trades after giving weak guidance for the fourth quarter.
Philip van Doorn
Citigroup: Shakeup Surprise Winner
State Street's shares rose 5% Tuesday following a strong earnings report, but the news was overshadowed by the resignation of Citigroup CEO Vikram Pandit.
Dan Freed
Bank of America's CEO Should Follow Pandit: Street Whispers
Finding a replacement to fix the brand and win over small business and consumers should be easier than it was a year ago.
Adam Feuerstein
NPS Pharma FDA Panel Live Blog
An FDA panel weighs the risk and benefits of NPS Pharma's Gattex.
Andrea Tse
Stocks Barely Budge to Wrap Dismal Week
All three major U.S. equity averages lose more than 2% for the week as the early returns on third-quarter earnings season prove discouraging.
Steve Cordasco
Sometimes There's Nothing Wrong With Staying on the Market Sidelines
Don't let anybody pressure you back into the stock market until you're ready.
Ted Reed
How Delta Transformed Vision into Reality in Paris and Seattle
Five years ago, a Delta executive spoke of his hopes to expand in Paris and Seattle.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Breakout Stocks
TRY IT FREEBryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.
Product Features:
- Model portfolio
- Small-cap and mid-cap focus
- Intraday trade alerts
- Weekly roundups
Stocks Under $10
TRY IT FREEJim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
|
|
Brokerage Partners
Most Commented
Articles From
Advertising Partners
| |
Special Features